Peritoneal Mast Cells in Peritoneal Dialysis Patients, Particularly in Encapsulating Peritoneal Sclerosis Patients

Williams, 2003, Peritoneal dialysis: Changes to the structure of the peritoneal membrane and potential for biocompatible solutions, Kidney Int Suppl, 84, S158, 10.1046/j.1523-1755.63.s84.46.x Wieczorowska-Tobis, 2004, Evidence for less irritation to the peritoneal membrane in rats dialyzed with solutions low in glucose degradation products, Perit Dial Int, 24, 48, 10.1177/089686080402400105 Wieczorowska-Tobis, 2001, Influence of neutral-pH dialysis solutions on the peritoneal membrane: A long-term investigation in rats, Perit Dial Int, 21, S108, 10.1177/089686080102103S18 Sitter, 2005, Impact of glucose in peritoneal dialysis: Saint or sinner?, Perit Dial Int, 25, 415, 10.1177/089686080502500502 Cancarini, 2000, The peritoneum during peritoneal dialysis, Perit Dial Int, 20, S37 Mortier, 2003, Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane, J Am Soc Nephrol, 14, 1296, 10.1097/01.ASN.0000060681.91079.30 Nakahata, 1986, Extensive proliferation of mature connective-tissue type mast cells in vitro, Nature, 324, 65, 10.1038/324065a0 Li, 2002, Mastocytosis and fibrosis: Role of cytokines, Int Arch Allergy Immunol, 127, 123, 10.1159/000048182 Hawkins, 1985, Increased dermal mast cell populations in progressive systemic sclerosis: A link in chronic fibrosis?, Ann Intern Med, 102, 182, 10.7326/0003-4819-102-2-182 Roberts, 2000, Mast cells: The forgotten cells of renal fibrosis, J Clin Pathol, 53, 858, 10.1136/jcp.53.11.858 Kondo, 2001, Role of mast cell tryptase in renal interstitial fibrosis, J Am Soc Nephrol, 12, 1668, 10.1681/ASN.V1281668 Honda, 2005, Pathology of encapsulating peritoneal sclerosis, Perit Dial Int, 25, S19, 10.1177/089686080502504S04 Williams, 2003, The natural course of peritoneal membrane biology during peritoneal dialysis, Kidney Int Suppl, 88, S43, 10.1046/j.1523-1755.2003.08805.x Mactier, 2000, The spectrum of peritoneal fibrosing syndromes in peritoneal dialysis, Adv Perit Dial, 16, 223 Nakamoto, 2005, Encapsulating peritoneal sclerosis—A clinician’s approach to diagnosis and medical treatment, Perit Dial Int, 25, S30, 10.1177/089686080502504S05 Williams, 2002, Morphologic changes in the peritoneal membrane of patients with renal disease, J Am Soc Nephrol, 13, 470, 10.1681/ASN.V132470 Fritz, 1989, Quantitative immunohistochemistry: Standardization and possible application in research and surgical pathology, Acta Histochem, 37, S213 Fritz, 1992, Quantitative immunohistochemistry, Prog Histochem Cytochem, 24, 1, 10.1016/S0079-6336(11)80214-7 Wieczorowska-Tobis, 2001, Morphologic aspects of chronic peritoneal dialysis in a rat model, Perit Dial Int, 21, S342, 10.1177/089686080102103S62 Bird, 1998, Mast cell histamine-induced calcium transients in cultured human peritoneal mesothelial cells, Perit Dial Int, 18, 626, 10.1177/089686089801800611 Zareie, 2001, Accumulation of omental mast cells during peritoneal dialysis, Perit Dial Int, 21, S373, 10.1177/089686080102103S71 Nakazato, 2002, Calcification and osteopontin localization in the peritoneum of patients on long-term continuous ambulatory peritoneal dialysis therapy, Nephrol Dial Transplant, 17, 1293, 10.1093/ndt/17.7.1293 Di Paolo, 2004, Ossification of the peritoneal membrane, Perit Dial Int, 24, 471, 10.1177/089686080402400513 Zareie, 2003, Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo, Nephrol Dial Transplant, 18, 2629, 10.1093/ndt/gfg356 Zareie, 2005, Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats, Nephrol Dial Transplant, 20, 189, 10.1093/ndt/gfh559 Qu, 1998, Ultrastructural immunolocalization of basic fibroblast growth factor in mast cell secretory granules, J Histochem Cytochem, 46, 1119, 10.1177/002215549804601004 Qu, 1995, Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma, Am J Pathol, 147, 564 Grutzkau, 1998, Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: Implications for the biological significance of VEGF206, Mol Biol Cell, 9, 875, 10.1091/mbc.9.4.875 Blair, 1997, Human mast cells stimulate vascular tube formation, J Clin Invest, 99, 2691, 10.1172/JCI119458 Muramatsu, 2000, Chymase as a proangiogenic factor, J Biol Chem, 275, 5545, 10.1074/jbc.275.8.5545 Heimburger, 1990, Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity, Kidney Int, 38, 495, 10.1038/ki.1990.231 Selgas, 1994, Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible?, Am J Kidney Dis, 23, 64, 10.1016/S0272-6386(12)80814-6 Winnen, 1921, Über Zuckergussdarm (peritonitis chronica fibrosa incapsulata), Brunns Beitr Klin Chir, 123, 72 Margetts, 2001, Gene transfer of transforming growth factor-beta1 to the rat peritoneum: Effects on membrane function, J Am Soc Nephrol, 12, 2029, 10.1681/ASN.V12102029 Margetts, 2002, Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum, Am J Pathol, 160, 2285, 10.1016/S0002-9440(10)61176-5 Nakamura, 2004, Advanced glycation end-products and peritoneal sclerosis, Semin Nephrol, 24, 502, 10.1016/j.semnephrol.2004.06.027 Alscher, 2005, The role of transforming growth factor (TGF) in encapsulating peritoneal sclerosis (EPS), J Am Soc Nephrol, 16, 265A Nakayama, 2005, The plasma leak-to-response hypothesis: A working hypothesis on the pathogenesis of encapsulating peritoneal sclerosis after long-term peritoneal dialysis treatment, Perit Dial Int, 25, S71, 10.1177/089686080502504S10 Schwartz, 1985, The fibrinogenolytic activity of purified tryptase from human lung mast cells, J Immunol, 135, 2762